Pharmaceutical Companies Can Improve ROIs, Reputations By Expanding Access To Medicines

Harvard Business Review: How Pharma Can Fix Its Reputation and Its Business at the Same Time
Damiano de Felice, deputy director of strategy at the Access to Medicine Foundation, discusses how research-based pharmaceutical companies can improve their return on investments and improve their reputations by “transform[ing] ‘access to medicine’ from a relentless activist slogan to a fully-fledged business strategy.” He writes, “[P]harma companies should develop innovative treatments for pervasive unmet medical needs; avoid corruption, collusion, and other unethical marketing practices; and make sure that their products reach as many patients around the world as possible…” (2/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.